Tumor Ablation Market 2024 | Size, Top Trends, Growth, Share, Key Drivers To 2033 | Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporationes Holdings BV

The Tumor Ablation Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Tumor Ablation Market:
https://www.thebusinessresearchcompany.com/report/tumor-ablation-global-market-report

According to The Business Research Company’s Tumor Ablation Global Market Report 2024, The tumor ablation market size is expected to see rapid growth in the next few years. It will grow to $2.27 billion in 2028 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to increasing cancer incidence, growing minimally invasive procedures, expanding applications, increasing healthcare cost-effectiveness, and growing awareness and education. Major trends in the forecast period include technological advancements, Continued development of advanced ablation technologies, integration of artificial intelligence, focus on outpatient settings, and patient-centric approaches.

The growth of minimally invasive procedures is expected to propel the growth of the tumor ablation market going forward. Minimally invasive procedures are medical or surgical interventions that require only small incisions or no incisions at all. The demand for minimally invasive procedures is on the rise due to their reduced recovery times, lower risk of complications, and lower post-operative pain compared to traditional surgeries. Tumor ablation is utilized in minimally invasive procedures to destroy cancerous tissues using techniques such as radiofrequency, microwave, or cryoablation, minimizing damage to surrounding healthy tissue and reducing recovery times. For instance, in January 2024, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported that they had placed 415 da Vinci surgical systems (robotic surgical systems that use a minimally invasive surgical approach) in the fourth quarter of 2023, representing a 12% increase compared to 2022. Therefore, the growth of minimally invasive procedures is driving the growth of the tumor ablation market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=17283&type=smp

The tumor ablation market covered in this report is segmented –

1) By Type: Thermal Ablation, Chemical Ablation
2) By Types Of Treatment: Percutaneous, Laparoscopic, Surgical
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Cancer
4) By End Users: Hospitals, Oncology Centers, Other End Users

Major companies operating in the tumor ablation market are developing innovative products, such as bone tumor ablation systems, to enhance treatment efficacy, improve patient outcomes, and expand the range of treatable tumors. A bone tumor ablation system is a specialized medical device used to treat bone tumors through minimally invasive procedures. For instance, in March 2024, Medtronic plc, an Ireland-based medical device company, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its OsteoCool 2.bone tumor ablation system. The upgraded system is designed to treat painful bone metastases and benign bone tumors such as osteoi osteoma. The OsteoCool 2.0 allows for the simultaneous use of four internally cooled probes, enabling physicians to ablate two vertebral bodies at once or create larger ablation zones in extra-spinal applications. It delivers 20W per channel, more than twice the power of the Stryker OptaBlateTM bone tumor ablation system.

The tumor ablation market report table of contents includes:

1. Executive Summary

2. Tumor Ablation Market Characteristics

3. Tumor Ablation Market Trends And Strategies

4. Tumor Ablation Market – Macro Economic Scenario

5. Global Tumor Ablation Market Size and Growth

…..

32. Global Tumor Ablation Market Competitive Benchmarking

33. Global Tumor Ablation Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Tumor Ablation Market

35. Tumor Ablation Market Future Outlook and Potential Analysis

36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model